Currently, there are 2.10B common shares owned by the public and among those 2.01B shares have been available to trade.
The company’s stock has a 5-day price change of -6.55% and 74.01% over the past three months. PLTR shares are trading 144.15% year to date (YTD), with the 12-month market performance up to 180.97% higher. It has a 12-month low price of $14.48 and touched a high of $45.14 over the same period. PLTR has an average intraday trading volume of 59.63 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.16%, 10.37%, and 52.57% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Palantir Technologies Inc (NYSE: PLTR) shares accounts for 43.02% of the company’s 2.10B shares outstanding.
It has a market capitalization of $94.69B and a beta (3y monthly) value of 2.70. The stock’s trailing 12-month PE ratio is 246.73, while the earnings-per-share (ttm) stands at $0.17. The company has a PEG of 10.06 and a Quick Ratio of 5.92 with the debt-to-equity ratio at 0.06. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.87% over the week and 3.47% over the month.
Earnings per share for the fiscal year are expected to increase by 42.50%, and 19.02% over the next financial year.
Northland Capital coverage for the Palantir Technologies Inc (PLTR) stock in a research note released on August 22, 2024 offered a Market Perform rating with a price target of $35. Monness Crespi & Hardt was of a view on August 06, 2024 that the stock is Sell, while Mizuho gave the stock Underperform rating on July 16, 2024, issuing a price target of $21- $22. Monness Crespi & Hardt on their part issued Sell rating on June 21, 2024.
